Carboline derivatives useful in the inhibition of angiogenesis

Details for Australian Patent Application No. 2005222632 (hide)

Owner PTC Therapeutics, Inc.

Inventors Cao, Liangxian; Choi, Soongyu; Qi, Hongyan; Lennox, William Joseph; Corson, Donald Thomas; Tamilarasu, Nadarajan; Moon, Young-Choon; Hwang, Seongwoo

Agent Spruson & Ferguson

Pub. Number AU-B-2005222632

PCT Pub. Number WO2005/089764

Priority 60/552,725 15.03.04 US

Filing date 15 March 2005

Wipo publication date 29 September 2005

Acceptance publication date 9 February 2012

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61K 31/497 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/5355 (2006.01) - Non-condensed oxazines containing further heterocyclic rings

A61K 31/541 (2006.01) - Non-condensed thiazines containing further heterocyclic rings

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/089764 Priority application(s): WO2005/089764

9 February 2012 Application Accepted

  Published as AU-B-2005222632

7 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005222633-Passive targeting of cytotoxic agents

2005222628-Pet food compositions containing an added boron source